Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

被引：3

作者：

Rodriguez-Lojo, R. ^{[1
]}

Almagro, M. ^{[1
]}

Barja, J. M. ^{[1
]}

Pineyro, F. ^{[1
]}

Perez-Varela, L. ^{[1
]}

Del Pozo, J. ^{[1
]}

Yebra-Pimentel, M. T. ^{[2
]}

Fonseca, E. ^{[1
]}

机构：

[1] Univ A Coruna, Complexo Hosp, Dept Dermatol, La Coruna 15006, Spain

[2] Univ A Coruna, Complexo Hosp, Dept Pathol, La Coruna 15006, Spain

来源：

DERMATOLOGY RESEARCH AND PRACTICE | 2010年 / 2010卷

关键词：

D O I：

10.1155/2010/230417

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.

引用

页数：3

共 11 条

[1] Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: Case report and review of literature [J].

Adla, Mahathi ;

Downey, Kathy K. ;

Ahmad, Jawad .

DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (10) :2810-2812

[2] Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences [J].

Blackard, Jason T. ;

Kemmer, Nyingi ;

Sherman, Kenneth E. .

HEPATOLOGY, 2006, 44 (01) :15-22

[3] Hepatitis C virus: a common triggering factor for both nodular vasculitis and Sjogren's syndrome? [J].

Cardinali, C ;

Gerlini, G ;

Caproni, M ;

Pimpinelli, N ;

Fabbri, P .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) :187-189

[4] Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection:: two cases [J].

Cogrel, O ;

Doutre, MS ;

Marlière, V ;

Beylot-Barry, M ;

Couzigou, P ;

Beylot, C .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (02) :320-324

[5] Pegylated interferon alfa-induced sarcoidosis:: two sides of the same coin [J].

Guilabert, A ;

Bosch, X ;

Julia, M ;

Iranzo, P ;

Mascaró, JM .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (02) :377-379

[6] Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus [J].

Hashimoto, Yuki ;

Kanto, Hiromi ;

Itoh, Masatoshi .

JOURNAL OF DERMATOLOGY, 2007, 34 (08) :577-582

[7] Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C - A case report and review of the literature [J].

Hurst, EA ;

Mauro, T .

ARCHIVES OF DERMATOLOGY, 2005, 141 (07) :865-868

[8] Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-α treatment for chronic hepatitis C and review of the literature [J].

Nawras, A ;

Alsolaiman, MM ;

Mehboob, S ;

Bartholomew, C ;

Maliakkal, B .

DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (07) :1627-1631

[9] Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C [J].

Rogers, CJ ;

Romagosa, R ;

Vincek, V .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (04) :649-650

[10] Sarcoidosis after use of interferon for chronic hepatitis C - Report of a case and review of the literature [J].

Tahan, V ;

Ozseker, F ;

Guneylioglu, D ;

Baran, A ;

Ozaras, R ;

Mert, A ;

Ucisik, AC ;

Cagatay, T ;

Yilmazbayhan, D ;

Senturk, H .

DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (01) :169-173

← 1 2 →